1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Systemic Aspergillosis and Systemic Candidasis Market – By Type
1.3.2 Systemic Aspergillosis and Systemic Candidasis Market – By Application
1.3.3 Asia Pacific Systemic Aspergillosis and Systemic Candidasis Market – By Geography
2. Systemic Aspergillosis And Systemic Candidasis Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Systemic Aspergillosis and Systemic Candidasis Market– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Expert Opinions
4.4 Clinical Trials Phases of Products Offered by Companies
4.5 Candida Specific Marketed Products
5. Asia Pacific Systemic Aspergillosis and Systemic Candidasis Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rise in Prevalence of Fungal Diseases
5.1.2 Rising Hospital Acquired Fungal Infection
5.2 Market Restraints
5.2.1 Increasing Resistance to Antifungal Drugs
5.2.2 Side Effects of Antifungal Drugs
5.3 Market Opportunities
5.3.1 Increase in R&D Activities and Pipeline of New Drug
5.4 Future Trends
5.4.1 Consolidation of Market
5.5 Impact Analysis
6. Systemic Aspergillosis and Systemic Candidasis Market Analysis– by Type
6.1 Overview
6.2 Asia Pacific Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2019 and 2027 (%)
6.3 Voriconazole
6.3.1 Overview
6.3.2 Asia Pacific Voriconazole Market Revenue and Forecasts to 2027 (US$ Mn)
6.4 Liposomal Amphotericin B
6.4.1 Overview
6.4.2 Asia Pacific Liposomal Amphotericin B Market Revenue and Forecasts to 2027 (US$ Mn)
6.5 Systemic Oral Azoles
6.5.1 Overview
6.5.2 Asia Pacific Systemic Oral Azoles Market Revenue and Forecasts to 2027 (US$ Mn)
6.6 Topical Antifungal Agents
6.6.1 Overview
6.6.2 Asia Pacific Topical Antifungal Agents Market Revenue and Forecasts to 2027 (US$ Mn)
6.7 Others
6.7.1 Overview
6.7.2 Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)
7. Asia Pacific Systemic Aspergillosis and Systemic Candidasis Market Analysis– by Application
7.1 Overview
7.2 Asia Pacific Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2019 and 2027 (%)
7.3 Chronic Pulmonary Aspergillosis (CPA)
7.3.1 Overview
7.3.2 Asia Pacific Chronic pulmonary aspergillosis (CPA) Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 Allergic Bronchopulmonary Aspergillosis (ABPA)
7.4.1 Overview
7.4.2 Asia Pacific Allergic bronchopulmonary aspergillosis (ABPA) Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Gastrointestinal Candidasis
7.5.1 Overview
7.5.2 Asia Pacific Gastrointestinal Candidasis Market Revenue and Forecasts to 2027 (US$ Mn)
7.6 Genitourinary Tract Candidasis
7.6.1 Overview
7.6.2 Asia Pacific Genitourinary Tract Candidasis Market Revenue and Forecasts to 2027 (US$ Mn)
7.7 Others
7.7.1 Overview
7.7.2 Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)
8. Asia Pacific Systemic Aspergillosis and Systemic Candidasis Market – Regional Analysis
8.1 Overview
8.1.1 Asia Pacific Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)
8.1.2 Asia Pacific Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2018–2027 (USD Million)
8.1.3 Asia Pacific Systemic Aspergillosis and Systemic Candidasis Market, by Application, 2018–2027 (USD Million)
8.1.4 Asia Pacific Systemic Aspergillosis and Systemic Candidasis Market, by Country, 2019 & 2027 (%)
8.1.5 China: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)
8.1.5.1 China: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)
8.1.5.2 China: Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2018–2027 (USD Million)
8.1.5.3 China: Systemic Aspergillosis and Systemic Candidasis Market, by Application, 2018–2027 (USD Million)
8.1.6 Japan: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)
8.1.6.1 Japan: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)
8.1.6.2 Japan: Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2018–2027 (USD Million)
8.1.6.3 Japan: Systemic Aspergillosis and Systemic Candidasis Market, by Application, 2018–2027 (USD Million)
8.1.7 India: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)
8.1.7.1 India: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)
8.1.7.2 India: Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2018–2027 (USD Million)
8.1.7.3 India: Systemic Aspergillosis and Systemic Candidasis Market, by Application, 2018–2027 (USD Million)
8.1.8 Australia: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)
8.1.8.1 Australia: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)
8.1.8.2 Australia: Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2018–2027 (USD Million)
8.1.8.3 Australia: Systemic Aspergillosis and Systemic Candidasis Market, by Application, 2018–2027 (USD Million)
8.1.9 South Korea: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)
8.1.9.1 South Korea: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)
8.1.9.2 South Korea: Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2018–2027 (USD Million)
8.1.9.3 South Korea: Systemic Aspergillosis and Systemic Candidasis Market, by Application, 2018–2027 (USD Million)
8.1.10 Rest of Asia Pacific: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)
8.1.10.1 Rest of Asia Pacific: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)
8.1.10.2 Rest of Asia Pacific: Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2018–2027 (USD Million)
8.1.10.3 Rest of Asia Pacific: Systemic Aspergillosis and Systemic Candidasis Market, by Application, 2018–2027 (USD Million)
9. Impact of COVID-19 Pandemic on Asia Pacific Systemic Aspergillosis and Systemic Candidasis Market
9.1 Impact Assessment of COVID-19 Pandemic
10. COMPANY PROFILES
10.1 Novartis AG
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Sanofi
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Pfizer Inc.
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Merck & Co., Inc.
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Bayer AG
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 Astellas Pharma Inc.
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 GlaxoSmithKline plc.
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Abbott
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 Cipla Inc.
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Products and Services
10.9.4 Financial Overview
10.9.5 Key Developments
11. Appendix
11.1 About the Insight Partners
11.2 Glossary of Terms